Levitas partners with Centogene, one of the world’s leading genetic laboratories, to provide clients with reliable, high-quality, and precise testing that meets the highest international standards.
Genetic Testing
General Information
A multiomic test that combines custom whole exome sequencing (WES) with biochemical markers, enzyme assays, and a medical report; includes automated reflex analysis for specific findings.
Technical Specifications
Covers ~20,000 genes and mtDNA; analyzes SNVs, InDels, CNVs, and structural variants; includes reflex confirmation using biomarkers or enzyme testing.
Sample & Conditions
Blood (EDTA), saliva, tissue, or dried blood spot (CentoCard®).
Turnaround time: ~30 days
Limitations / Recommendations
Suitable for complex and undiagnosed cases; some variants may remain undetected.
Price
€915
General Information
Whole Genome Sequencing (WGS) within the MOx framework — combines genomic analysis with biochemical testing; provides more complete coverage of intronic and non-coding regions compared to WES.
Technical Specifications
Includes WGS + mtDNA + CNV analysis; MOx 2.0 also incorporates RNA analysis for splicing effects (when applicable).
Sample & Conditions
Blood, tissue, or CentoCard®
Turnaround time: ~30–40 days
Limitations / Recommendations
Best suited for complex cases or when WES yields negative results.
Price
€2,395
General Information
A version of MOx that adds RNA (transcriptomic) analysis to WES and biochemical testing, enhancing the detection of splicing and regulatory variants.
Technical Specifications
WES + mtDNA + CNV + RNA analysis; includes additional biochemical markers.
Sample & Conditions
Requires specific storage and transport conditions for RNA analysis; typically performed using a dried blood spot or EDTA blood with expedited delivery.
Turnaround time: ~30–40 days
Limitations / Recommendations
Recommended for cases where splicing effects are suspected.
Price
€1830
General Information
WGS combined with biochemical markers and RNA analysis (MOx 2.0) for a highly detailed multiomic approach.
Technical Specifications
WGS covers intronic and regulatory regions; RNA analysis adds expression and splicing data.
Sample & Conditions
Blood or tissue; special handling required for RNA analysis.
Turnaround time: ~30–45 days
Limitations / Recommendations
Offers the broadest coverage, ideal for complex or hard-to-diagnose cases.
Price
€3370
General Information
Combines genetic analysis and biochemical testing for the diagnosis of inborn metabolic disorders (IMD).
Technical Specifications
Samples: EDTA blood, plasma, or dried blood spots (suitable for newborn screening).
Sample & Conditions
Blood or tissue; special handling required for RNA when applicable.
Turnaround time: ~2–4 weeks
Limitations / Recommendations
Most useful in neonatal crises or suspected cases of IMD.
Price
€510
General Information
Whole Exome Sequencing (WES) for a single patient (Solo).
Technical Specifications
Same as CentoXome: WES, mtDNA analysis, and CNV detection.
Sample & Conditions
EDTA blood
Turnaround time: ~30 days
Limitations / Recommendations
If necessary, Duo or Trio testing can be offered to increase diagnostic yield.
Price
€1120
General Information
Whole Genome Sequencing (WGS) for a single patient (Solo) — a comprehensive genomic analysis for full diagnostic insight.
Technical Specifications
Complete genome sequencing; includes analysis of structural and non-coding variants.
Sample & Conditions
Blood or tissue
Turnaround time: ~30–45 days
Limitations / Recommendations
Including Trio or accompanying samples increases diagnostic accuracy.
Price
€2440
General Information
Prenatal/reproductive screening using genomic methods to assess risk and detect variants associated with inherited disorders.
Technical Specifications
May include WES/WGS or targeted panels; typically screens for known pathogenic variants linked to reproductive risk.
Sample & Conditions
Parental blood samples and/or fetal material, depending on the test performed.
Limitations / Recommendations
Screening does not provide absolute certainty; genetic counseling is recommended for any findings.
Price
€1015
General Information
Microarray (array-based) analysis for CNVs, enabling high-resolution detection of deletions and duplications.
Technical Specifications
CGH/SNP array; high sensitivity for submicroscopic CNVs.
Sample & Conditions
Blood or DNA
Turnaround time: ~2–3 weeks
Limitations / Recommendations
Does not detect point mutations; commonly used for congenital anomalies and genetic syndromes.
Price
€730
General Information
This panel/test is designed for the diagnosis of the clinical condition specified in the title. It typically includes a selected set of genes known to be associated with the specific disease or syndrome and uses NGS (panel-based sequencing) or other molecular methods (MLPA, Sanger, qPCR) for detecting certain variants.
Technical Specifications
Typically: NGS gene panel (amplicon-based or hybrid capture) covering tens to hundreds of genes.
Possible additions: CNV analysis, repeat expansions, mtDNA testing if required.
Validation: Sanger sequencing or MLPA for key variants when needed.
Sample & Conditions
EDTA blood is the most common sample type; in some cases, saliva or tissue may be used.
Turnaround Time
Usually 2–6 weeks, depending on the panel and required reflex testing.
Limitations / Recommendations
Panels cover a predefined set of genes; a negative result does not rule out a genetic cause outside the tested genes.
For broader investigations, WES/WGS or multiomic approaches are recommended.
Price
€812
General Information
This panel is focused on diagnosing amyotrophic lateral sclerosis (ALS) and dementia-related disorders. It typically includes a selected set of genes known to be associated with these conditions, analyzed using NGS (panel-based sequencing) or specific molecular methods (MLPA, Sanger sequencing, qPCR) for certain variants.
Technical Specifications
Primary method: NGS panel (amplicon-based or hybrid capture) covering tens to hundreds of genes
Possible additions: CNV analysis, repeat expansions, mtDNA when required
Validation: Sanger or MLPA confirmation for key variants as needed
Sample & Conditions
EDTA blood is most commonly used; saliva or tissue may be accepted in some cases.
Turnaround Time
Approximately 2–6 weeks depending on panel size and reflex testing requirements.
Limitations / Recommendations
Panels cover a predefined set of genes; a negative result does not rule out a genetic cause outside the tested regions.
For broader investigation, WES/WGS or multiomic testing is recommended.
Price
€1220
General Information
This panel is focused on the diagnosis of ataxia and hereditary spastic paraplegia. It typically includes a selected set of genes known to be associated with these conditions, analyzed via NGS (panel-based sequencing) or specific molecular methods (MLPA, Sanger sequencing, qPCR) for certain variants.
Technical Specifications
Primary method: NGS gene panel (amplicon-based or hybrid capture) covering tens to hundreds of genes
Possible additions: CNV analysis, repeat expansions, mtDNA if clinically indicated
Validation: Sanger sequencing or MLPA for key variants when required
Sample & Conditions
EDTA blood is most commonly used; saliva or tissue samples may be accepted in some cases.
Turnaround Time
Approximately 2–6 weeks, depending on panel complexity and necessary reflex testing.
Limitations / Recommendations
The panel covers a predefined set of genes; a negative result does not rule out a genetic cause outside the tested genes.
For broader diagnostic insight, WES/WGS or multiomic solutions are recommended.
Price
€812
General Information
This panel is designed to diagnose the clinical conditions stated in the title. It typically includes a carefully selected set of genes known to be associated with ataxia and hereditary spastic paraplegia, analyzed via NGS (panel-based sequencing) or specific molecular methods (MLPA, Sanger sequencing, qPCR) for certain variants.
Technical Specifications
Primary method: NGS gene panel (amplicon-based or hybrid capture) covering tens to hundreds of genes
Possible additions: CNV analysis, repeat expansions, mtDNA testing if required
Validation: Sanger sequencing or MLPA for key variants when needed
Sample & Conditions
EDTA blood is most commonly used; saliva or tissue samples may be accepted depending on the case.
Turnaround Time
Typically 2–6 weeks, depending on panel complexity and required reflex testing.
Limitations / Recommendations
Panels cover a predefined set of genes; a negative result does not exclude a genetic cause outside of the tested regions.
For broader investigation, WES/WGS or multiomic testing is recommended.
Price
€2538
General Information
This panel is designed to diagnose conditions associated with repeat expansion disorders that lead to ataxia. It typically includes a selected set of genes known to be implicated in such disorders and is analyzed using NGS (panel-based sequencing) or specific molecular methods (MLPA, Sanger sequencing, qPCR) for certain variants.
Technical Specifications
Primary method: NGS gene panel (amplicon-based or hybrid capture) covering tens to hundreds of genes
Possible additions: CNV analysis, repeat expansion detection, mtDNA testing if clinically relevant
Validation: Sanger sequencing or MLPA for key variants when required
Sample & Conditions
EDTA blood is the most commonly used sample type; saliva or tissue may be accepted in specific situations.
Turnaround Time
Typically 2–6 weeks, depending on panel complexity and required reflex testing.
Limitations / Recommendations
Panels include predefined genes; a negative result does not exclude a genetic cause outside the tested regions.
For broader diagnostic insight, WES/WGS or multiomic testing is recommended.
Price
€1726
General Information
This panel is designed for the diagnosis of atypical hemolytic uremic syndrome (aHUS). It typically includes a selected set of genes known to be associated with the condition and is analyzed using NGS (panel-based sequencing) or specific molecular methods (MLPA, Sanger sequencing, qPCR) for particular variants.
Technical Specifications
Primary method: NGS gene panel (amplicon-based or hybrid capture) covering tens to hundreds of genes
Possible additions: CNV analysis, repeat expansions, mtDNA if clinically indicated
Validation: Sanger sequencing or MLPA for key variants as needed
Sample & Conditions
EDTA blood is most commonly used; saliva or tissue samples may be accepted in certain cases.
Turnaround Time
Typically 2–6 weeks, depending on panel complexity and required reflex testing.
Limitations / Recommendations
Panels include a predefined gene set; a negative result does not rule out a genetic cause outside the tested genes.
Broader testing such as WES/WGS or multiomic approaches is recommended for expanded diagnostic assessment.
Price
€1218
General Information
This panel is designed for the diagnosis of coagulopathies. It typically includes a selected set of genes known to be associated with blood clotting disorders and is analyzed using NGS (panel-based sequencing) or specific molecular methods (MLPA, Sanger sequencing, qPCR) for certain variants.
Technical Specifications
Primary method: NGS gene panel (amplicon-based or hybrid capture) covering tens to hundreds of genes
Possible additions: CNV analysis, repeat expansions, mtDNA if clinically indicated
Validation: Sanger sequencing or MLPA for key variants when required
Sample & Conditions
EDTA blood is most commonly used; saliva or tissue samples may be accepted in certain cases.
Turnaround Time
Typically 2–6 weeks, depending on panel complexity and required reflex testing.
Limitations / Recommendations
Panels include predefined genes; a negative result does not exclude a genetic cause outside the tested regions.
Broader testing such as WES/WGS or multiomic approaches may be recommended for comprehensive diagnostic evaluation.
Price
€914
General Information
This panel is designed for the diagnosis of bone marrow failure syndromes and genetic forms of anemia. It typically includes a selected set of genes known to be associated with these conditions, analyzed using NGS (panel-based sequencing) or specific molecular methods (MLPA, Sanger sequencing, qPCR) for certain variants.
Technical Specifications
Primary method: NGS gene panel (amplicon-based or hybrid capture) covering tens to hundreds of genes
Possible additions: CNV analysis, repeat expansions, mtDNA testing if clinically indicated
Validation: Sanger sequencing or MLPA for key variants when necessary
Sample & Conditions
EDTA blood is the most commonly used sample type; saliva or tissue may be accepted in some cases.
Turnaround Time
Usually 2–6 weeks, depending on panel size and any required reflex testing.
Limitations / Recommendations
Panels cover a predefined set of genes; a negative result does not rule out a genetic cause outside of the tested regions.
For more comprehensive evaluation, WES/WGS or multiomic approaches may be recommended.
Price
€815
General Information
This panel is designed to diagnose hereditary breast and ovarian cancer syndromes associated with BRCA1 and BRCA2 gene mutations. It typically includes sequencing and analysis of these key genes using NGS (panel-based sequencing) or specific molecular methods (MLPA, Sanger sequencing, qPCR) for certain variants.
Technical Specifications
Primary method: NGS gene panel (amplicon-based or hybrid capture) covering selected genes
Possible additions: CNV analysis, repeat expansions, mtDNA if clinically relevant
Validation: Sanger sequencing or MLPA for confirmation of key variants when required
Sample & Conditions
EDTA blood is most commonly used; saliva or tissue may be accepted in some cases.
Turnaround Time
Typically 2–6 weeks, depending on testing requirements and reflex analyses.
Limitations / Recommendations
The panel includes a predefined set of genes; a negative result does not exclude a genetic cause outside the tested genes.
For broader investigation, WES/WGS or multiomic solutions may be recommended.
Price
€711
General Information
This panel is designed to diagnose hereditary breast, ovarian, and related cancers by analyzing BRCA1 and BRCA2, along with additional genes associated with these conditions. It uses NGS (panel-based sequencing) or specific molecular methods (MLPA, Sanger sequencing, qPCR) for selected variants.
Technical Specifications
Primary method: NGS gene panel (amplicon-based or hybrid capture) covering multiple relevant genes
Possible additions: CNV analysis, repeat expansions, mtDNA if clinically required
Validation: Sanger sequencing or MLPA for key variants if necessary
Sample & Conditions
EDTA blood is the most commonly used sample; saliva or tissue may be accepted in some cases.
Turnaround Time
Typically 2–6 weeks, depending on the panel and any required reflex testing.
Limitations / Recommendations
The panel includes a predefined set of genes; a negative result does not exclude a genetic cause outside the tested regions.
For broader assessment, WES/WGS or multiomic analysis may be recommended.
Price
€610
General Information
This panel is designed to detect somatic mutations in BRCA1 and BRCA2 genes, commonly associated with tumor profiling and targeted cancer therapies. It typically involves sequencing of selected genes using NGS (panel-based sequencing) or specific molecular methods (MLPA, Sanger sequencing, qPCR) for detecting certain variant types.
Technical Specifications
Primary method: NGS panel (amplicon-based or hybrid capture) covering select genes
Possible additions: CNV analysis, repeat expansions, mtDNA if clinically required
Validation: Sanger sequencing or MLPA for key variant confirmation when needed
Sample & Conditions
EDTA blood is commonly used; tumor tissue samples may also be accepted depending on the clinical requirement.
Turnaround Time
Typically 2–6 weeks, depending on panel complexity and reflex testing needs.
Limitations / Recommendations
The panel covers predefined genes; a negative result does not exclude genetic causes outside the tested regions.
For broader genomic insights, WES/WGS or multiomic testing may be recommended.
Price
€696
General Information
This panel is designed for the diagnosis of hereditary breast cancer and related syndromes. It includes a selected set of genes known to be associated with these conditions and is analyzed using NGS (panel-based sequencing) or specific molecular methods (MLPA, Sanger sequencing, qPCR) for particular variants.
Technical Specifications
Primary method: NGS gene panel (amplicon-based or hybrid capture) covering tens to hundreds of genes
Possible additions: CNV analysis, repeat expansions, mtDNA testing if clinically indicated
Validation: Sanger sequencing or MLPA for confirmation of key variants when necessary
Sample & Conditions
EDTA blood is the most commonly used sample; saliva or tissue samples may be accepted in some cases.
Turnaround Time
Typically 2–6 weeks, depending on panel complexity and required reflex testing.
Limitations / Recommendations
Panels include a predefined set of genes; a negative result does not exclude genetic causes outside the tested regions.
For broader genomic evaluation, WES/WGS or multiomic solutions may be recommended.
Price
€711
General Information
This panel is designed for the diagnosis of hereditary cancer syndromes. It includes a selected set of genes known to be associated with increased cancer risk, analyzed using NGS (panel-based sequencing) or specific molecular methods (MLPA, Sanger sequencing, qPCR) for certain variant types.
Technical Specifications
Primary method: NGS gene panel (amplicon-based or hybrid capture), covering tens to hundreds of genes
Possible additions: CNV analysis, repeat expansions, mtDNA testing if clinically relevant
Validation: Sanger sequencing or MLPA for confirmation of key variants when needed
Sample & Conditions
EDTA blood is the most commonly used sample; saliva or tissue may also be accepted in certain cases.
Turnaround Time
Typically 2–6 weeks, depending on the panel and any required reflex testing.
Limitations / Recommendations
Panels include a predefined set of genes; a negative result does not exclude a genetic cause outside the tested regions.
For broader diagnostic investigation, WES/WGS or multiomic analysis may be recommended.
Price
€710
General Information
This panel is designed for the diagnosis of hereditary cancer syndromes. It includes an expanded set of genes known to be associated with increased cancer risk and is analyzed using NGS (panel-based sequencing) or specific molecular methods (MLPA, Sanger sequencing, qPCR) for select genetic variants.
Technical Specifications
Primary method: NGS gene panel (amplicon-based or hybrid capture), covering tens to hundreds of genes
Possible additions: CNV analysis, repeat expansion detection, mtDNA testing if clinically indicated
Validation: Sanger sequencing or MLPA used for confirmation of key variants when necessary
Sample & Conditions
EDTA blood is the most common sample type; saliva or tissue may be accepted in certain cases.
Turnaround Time
Typically 2–6 weeks, depending on panel size and required reflex testing.
Limitations / Recommendations
The panel covers a predefined set of genes; a negative result does not rule out a genetic cause beyond those tested.
For broader genomic evaluation, WES/WGS or multiomic analysis may be recommended.
Price
€915
General Information
This panel is designed for the diagnosis of hereditary pediatric cancers. It includes a selected set of genes known to be associated with childhood-onset cancer syndromes and is analyzed using NGS (panel-based sequencing) or specific molecular methods (MLPA, Sanger sequencing, qPCR) for particular variants.
Technical Specifications
Primary method: NGS gene panel (amplicon-based or hybrid capture), covering tens to hundreds of genes
Possible additions: CNV analysis, repeat expansion detection, mtDNA testing if clinically relevant
Validation: Sanger sequencing or MLPA for confirmation of key variants when required
Sample & Conditions
EDTA blood is the most commonly used sample; saliva or tissue may be accepted in specific clinical scenarios.
Turnaround Time
Typically 2–6 weeks, depending on panel size and any required reflex testing.
Limitations / Recommendations
Panels test a predefined set of genes; a negative result does not exclude a genetic cause beyond the tested genes.
Broader testing such as WES/WGS or multiomic analysis may be recommended for complex or inconclusive cases.
Price
€915
General Information
This panel is designed to assess genetic predisposition to cancer by analyzing key genes associated with increased cancer risk. Testing is performed using NGS (panel-based sequencing) or specific molecular methods (MLPA, Sanger sequencing, qPCR) for select variant types.
Technical Specifications
Primary method: NGS gene panel (amplicon-based or hybrid capture) covering tens to hundreds of genes
Possible additions: CNV analysis, repeat expansion detection, mtDNA testing if clinically indicated
Validation: Sanger sequencing or MLPA used for confirmation of key variants when necessary
Sample & Conditions
EDTA blood is the most commonly used sample; saliva or tissue may be accepted in some cases.
Turnaround Time
Typically 2–6 weeks, depending on panel complexity and any required reflex testing.
Limitations / Recommendations
The panel covers a predefined set of genes; a negative result does not exclude a genetic cause outside the tested genes.
For broader evaluation, WES/WGS or multiomic analysis may be recommended.
Price
€715
General Information
This panel is designed for the diagnosis of hereditary cardiovascular disorders. It includes a selected set of genes known to be associated with conditions such as cardiomyopathies, arrhythmias, and vascular disorders. Testing is performed using NGS (panel-based sequencing) or specific molecular methods (MLPA, Sanger sequencing, qPCR) for certain variant types.
Technical Specifications
Primary method: NGS gene panel (amplicon-based or hybrid capture) covering tens to hundreds of genes
Possible additions: CNV analysis, repeat expansion detection, mtDNA testing if clinically indicated
Validation: Sanger sequencing or MLPA for confirmation of key variants when necessary
Sample & Conditions
EDTA blood is commonly used; saliva or tissue samples may be accepted depending on the case.
Turnaround Time
Typically 2–6 weeks, depending on panel size and reflex testing requirements.
Limitations / Recommendations
Panels include a predefined set of genes; a negative result does not exclude a genetic cause outside the tested regions.
For broader diagnostic investigation, WES/WGS or multiomic analysis may be recommended.
Price
€815
General Information
This panel is designed for the diagnosis of genetic syndromes associated with dysmorphic features and developmental anomalies. It includes a selected set of genes known to be linked to such conditions and is analyzed using NGS (panel-based sequencing) or specific molecular methods (MLPA, Sanger sequencing, qPCR) for particular variant types.
Technical Specifications
Primary method: NGS gene panel (amplicon-based or hybrid capture) covering tens to hundreds of genes
Possible additions: CNV analysis, repeat expansions, mtDNA testing if clinically indicated
Validation: Sanger sequencing or MLPA for confirmation of key variants when necessary
Sample & Conditions
EDTA blood is the most commonly used sample type; saliva or tissue may be accepted in specific cases.
Turnaround Time
Typically 2–6 weeks, depending on panel complexity and required reflex testing.
Limitations / Recommendations
The panel tests a predefined set of genes; a negative result does not exclude a genetic cause outside the tested regions.
For broader diagnostic insight, WES/WGS or multiomic testing may be recommended.
Price
€815
General Information
This panel is designed for the diagnosis of hereditary hearing loss and related otological disorders. It includes a selected set of genes known to be associated with syndromic and non-syndromic forms of hearing impairment, analyzed using NGS (panel-based sequencing) or specific molecular methods (MLPA, Sanger sequencing, qPCR) for select variant types.
Technical Specifications
Primary method: NGS gene panel (amplicon-based or hybrid capture) covering tens to hundreds of genes
Possible additions: CNV analysis, repeat expansion detection, mtDNA testing if clinically indicated
Validation: Sanger sequencing or MLPA for confirmation of key variants when required
Sample & Conditions
EDTA blood is the most commonly used sample. Saliva or tissue may also be accepted in certain cases.
Turnaround Time
Typically 2–6 weeks, depending on panel complexity and required reflex tests.
Limitations / Recommendations
The panel includes a predefined set of genes; a negative result does not exclude a genetic cause outside the tested regions.
For broader diagnostic evaluation, WES/WGS or multiomic testing may be recommended.
Price
€812
General Information
This panel is designed for rapid and targeted genetic diagnosis in critical care settings, including neonatal and pediatric intensive care units. It includes a selected set of genes associated with life-threatening genetic conditions and syndromes, analyzed using NGS (panel-based sequencing) or specific molecular methods (MLPA, Sanger sequencing, qPCR) for certain variant types.
Technical Specifications
Primary method: NGS gene panel (amplicon-based or hybrid capture), covering tens to hundreds of genes
Possible additions: CNV analysis, repeat expansion detection, mtDNA testing if clinically indicated
Validation: Sanger sequencing or MLPA for confirmation of key variants when necessary
Sample & Conditions
EDTA blood is the most commonly used sample; saliva or tissue may be accepted depending on the clinical scenario.
Turnaround Time
Typically 2–6 weeks, depending on panel size and the need for reflex testing.
Limitations / Recommendations
The panel targets a predefined set of genes; a negative result does not exclude a genetic cause outside the tested regions.
For more comprehensive evaluation, WES/WGS or multiomic approaches may be recommended.
Price
€1120
General Information
This panel is designed for the diagnosis of inborn errors of metabolism (IEM). It includes a selected set of genes known to be associated with metabolic disorders and is analyzed using NGS (panel-based sequencing) or specific molecular methods (MLPA, Sanger sequencing, qPCR) for certain variant types.
Technical Specifications
Primary method: NGS gene panel (amplicon-based or hybrid capture), covering tens to hundreds of genes
Possible additions: CNV analysis, repeat expansion detection, mtDNA testing if clinically indicated
Validation: Sanger sequencing or MLPA for confirmation of key variants when required
Sample & Conditions
EDTA blood is the most commonly used sample; saliva or tissue may also be accepted in specific cases.
Turnaround Time
Typically 2–6 weeks, depending on the panel and any required reflex testing.
Limitations / Recommendations
Panels cover predefined genes; a negative result does not exclude a genetic cause outside the tested regions.
For broader evaluation, WES/WGS or multiomic analysis may be recommended in complex or inconclusive cases.
Price
€812
General Information
This panel/test is designed for the diagnosis of disorders within the clinical area indicated in the title. It typically includes a curated set of genes known to be associated with specific immunological diseases or syndromes. Analysis is performed using NGS (panel-based sequencing) or specialized molecular methods such as MLPA, Sanger sequencing, or qPCR for select variant types.
Technical Specifications
Primary method: NGS panel (amplicon-based or hybrid capture) covering tens to hundreds of genes
Optional additions: CNV analysis, repeat expansion detection, mtDNA testing when clinically indicated
Validation: Sanger sequencing or MLPA for key variants as needed
Sample & Conditions
EDTA blood is the most commonly used sample type; saliva or tissue may also be acceptable depending on the test requirements.
Turnaround Time
Typically 2–6 weeks, depending on the panel and any reflex testing required.
Limitations / Recommendations
Gene panels cover predefined regions; a negative result does not exclude a genetic cause outside the tested genes.
For broader or unresolved cases, WES/WGS or multiomic approaches may be recommended.
Price
€812
General Information
This panel/test is designed to diagnose disorders related to the clinical area specified in the title, focusing on mitochondrial diseases. It typically includes a curated selection of genes known to be associated with mitochondrial dysfunction and related syndromes. Analysis is performed using NGS (targeted panel sequencing) or specialized molecular techniques such as MLPA, Sanger sequencing, or qPCR for certain variant types.
Technical Specifications
Primary Method: NGS panel (amplicon-based or hybrid capture) covering tens to hundreds of genes
Optional Add-ons: CNV analysis, repeat expansion detection, mitochondrial DNA (mtDNA) sequencing where applicable
Validation: Sanger sequencing or MLPA for key variants as needed
Sample & Conditions
EDTA blood is the most commonly used sample type; saliva or tissue may also be acceptable depending on the test.
Turnaround Time
Typically 2–6 weeks, depending on the panel and any reflex testing required.
Limitations / Recommendations
Panels cover predefined gene regions; a negative result does not exclude a genetic cause outside the tested genes.
For broader or inconclusive cases, WES/WGS or multiomic solutions are recommended.
Price
€915
General Information
This panel/test is designed for the diagnosis of mitochondrial disorders, as specified in the title. It typically includes a selected set of genes known to be associated with mitochondrial diseases or related syndromes. Testing is performed using Next-Generation Sequencing (NGS) panels or specialized molecular methods such as MLPA, Sanger sequencing, or qPCR for specific variant types.
Technical Specifications
Primary Method: NGS panel (amplicon-based or hybrid capture) covering dozens to hundreds of genes
Possible Add-ons: CNV analysis, repeat expansion detection, mitochondrial DNA (mtDNA) sequencing where applicable
Validation: Sanger sequencing or MLPA for key variants when necessary
Sample & Conditions
EDTA blood is the most commonly used sample type; saliva or tissue samples may also be accepted depending on the case.
Turnaround Time
Typically 2–6 weeks, depending on the panel and any reflex testing required.
Limitations / Recommendations
Panels cover predefined gene sets; a negative result does not exclude a genetic cause outside the tested regions.
For broader or inconclusive cases, Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), or multiomic approaches are recommended.
Price
€580
General Information
This panel/test is designed to diagnose the clinical condition specified in the title. It typically includes a selected set of genes known to be associated with the relevant disease or syndrome. Testing is performed via Next-Generation Sequencing (NGS) panels or specialized molecular methods such as MLPA, Sanger sequencing, or qPCR for specific variants.
Technical Specifications
Primary Method: NGS panel (amplicon-based or hybrid capture) covering dozens to hundreds of genes
Possible Add-ons: CNV analysis, repeat expansion detection, mtDNA sequencing where applicable
Validation: Sanger sequencing or MLPA for key variants when required
Sample & Conditions
EDTA blood is the most commonly used sample type; saliva or tissue may also be accepted.
Turnaround Time
Typically 2–6 weeks, depending on the panel and any reflex testing needed.
Limitations / Recommendations
Panels cover predefined gene sets; a negative result does not exclude a genetic cause outside the tested regions.
For broader diagnostic insight, Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), or multiomic solutions are recommended.
Price
€812
General Information
This panel/test is intended for the diagnosis of the clinical condition specified in the title. It typically includes a selected set of genes known to be associated with the relevant disease or syndrome. Testing is performed using Next-Generation Sequencing (NGS) panels or specialized molecular methods such as MLPA, Sanger sequencing, or qPCR for specific variant types.
Technical Specifications
Primary Method: NGS panel (amplicon-based or hybrid capture), covering dozens to hundreds of genes
Possible Add-ons: CNV analysis, repeat expansion testing, mtDNA sequencing where applicable
Validation: Sanger sequencing or MLPA for key variants when necessary
Sample & Conditions
EDTA blood is the most commonly used sample type; saliva or tissue may also be accepted.
Turnaround Time
Typically 2–6 weeks, depending on the panel and any reflex testing required.
Limitations / Recommendations
Panels cover predefined gene sets; a negative result does not exclude a genetic cause outside the tested regions.
For broader or more complex cases, Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), or multiomic solutions are recommended.
Price
€1220
General Information
This panel/test is intended for the diagnosis of the clinical condition specified in the title. It typically includes a selected set of genes known to be associated with the specific disease or syndrome, using Next-Generation Sequencing (NGS) panels or specialized molecular methods such as MLPA, Sanger sequencing, or qPCR for certain variants.
Technical Specifications
Primary Method: NGS panel (amplicon-based or hybrid capture) covering dozens to hundreds of genes
Possible Add-ons: CNV analysis, repeat expansion testing, mtDNA sequencing as needed
Validation: Sanger sequencing or MLPA for key variants when required
Sample & Conditions
EDTA blood is the most commonly used sample type; saliva or tissue may also be used.
Turnaround Time
Typically 2–6 weeks, depending on the panel and any reflex testing needed.
Limitations / Recommendations
Panels cover predefined gene sets; a negative result does not exclude a genetic cause outside the target regions.
For broader analysis, Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), or multiomic approaches are recommended.
Price
€812
General Information
This panel/test is intended for the diagnosis of the clinical condition specified in the title. It typically includes a selected set of genes known to be associated with the specific disease or syndrome, using Next-Generation Sequencing (NGS) panels or specialized molecular methods such as MLPA, Sanger sequencing, or qPCR for certain variants.
Technical Specifications
Primary Method: NGS panel (amplicon-based or hybrid capture), covering dozens to hundreds of genes
Possible Add-ons: CNV analysis, repeat expansion testing, mtDNA sequencing as needed
Validation: Sanger sequencing or MLPA for key variants when required
Sample & Conditions
EDTA blood is the most commonly used sample type; saliva or tissue may also be accepted.
Turnaround Time
Typically 2–6 weeks, depending on the panel and any reflex testing required.
Limitations / Recommendations
Panels are limited to predefined gene sets; a negative result does not exclude a genetic cause outside the covered regions.
For broader diagnostic insight, Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), or multiomic solutions are recommended.
Price
€812
General Information
This panel/test is designed for the diagnosis of the clinical condition specified in the title. It typically includes a selected set of genes known to be associated with the specific disease or syndrome, analyzed using Next-Generation Sequencing (NGS) panels or specialized molecular methods such as MLPA, Sanger sequencing, or qPCR for certain variants.
Technical Specifications
Primary Method: NGS panel (amplicon-based or hybrid capture) covering dozens to hundreds of genes
Possible Add-ons: CNV analysis, repeat expansion testing, mtDNA sequencing if needed
Validation: Sanger sequencing or MLPA for key variants when required
Sample & Conditions
EDTA blood is the most commonly used sample; saliva or tissue samples may also be accepted.
Turnaround Time
Typically 2–6 weeks, depending on the panel and any reflex testing required.
Limitations / Recommendations
Panels cover predefined gene sets; a negative result does not exclude a genetic cause outside the targeted regions.
For more comprehensive analysis, Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), or multiomic approaches are recommended.
Price
€815
General Information
This panel/test is designed for the diagnosis of congenital adrenal hyperplasia (CAH). It typically includes a selected set of genes known to be associated with this condition, analyzed using Next-Generation Sequencing (NGS) panels or specialized molecular methods such as MLPA, Sanger sequencing, or qPCR for certain variants.
Technical Specifications
Primary Method: NGS panel (amplicon-based or hybrid capture), covering dozens to hundreds of genes
Possible Add-ons: CNV analysis, repeat expansion testing, mtDNA sequencing when applicable
Validation: Sanger sequencing or MLPA performed as needed for key variants
Sample & Conditions
EDTA blood is the most commonly used sample; saliva or tissue may also be accepted.
Turnaround Time
Typically 2–6 weeks, depending on the panel and any required reflex testing.
Limitations / Recommendations
Panels target predefined gene sets; a negative result does not exclude a genetic cause outside the covered regions.
For broader diagnostic insights, Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), or multiomic solutions are recommended.
Price
€1220
General Information
This panel/test is designed for the diagnosis of the clinical condition described in the title. It typically includes a selected set of genes known to be associated with specific connective tissue disorders, analyzed using Next-Generation Sequencing (NGS) panels or specialized molecular methods such as MLPA, Sanger sequencing, or qPCR for certain variants.
Technical Specifications
Primary Method: NGS panel (amplicon-based or hybrid capture) covering dozens to hundreds of genes
Possible Add-ons: CNV analysis, repeat expansion testing, mtDNA sequencing as needed
Validation: Sanger sequencing or MLPA performed as required for key variants
Sample & Conditions
EDTA blood is the most commonly used sample; saliva or tissue may also be accepted.
Turnaround Time
Typically 2–6 weeks, depending on the panel and any reflex testing required.
Limitations / Recommendations
Panels cover predefined gene sets; a negative result does not exclude a genetic cause outside the targeted regions.
For broader diagnostic insight, Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), or multiomic approaches are recommended.
Price
€812
General Information
This panel/test is designed to diagnose the clinical conditions associated with diabetes and obesity. It typically includes a selected set of genes known to be related to these disorders, analyzed using Next-Generation Sequencing (NGS) panels or specialized molecular methods such as MLPA, Sanger sequencing, or qPCR for specific variants.
Technical Specifications
Primary Method: NGS panel (amplicon-based or hybrid capture) covering dozens to hundreds of genes
Possible Add-ons: CNV analysis, repeat expansion testing, mtDNA sequencing as needed
Validation: Sanger sequencing or MLPA for key variants when required
Sample & Conditions
EDTA blood is the most commonly used sample; saliva or tissue may also be accepted.
Turnaround Time
Typically 2–6 weeks, depending on the panel and any necessary reflex testing.
Limitations / Recommendations
Panels target predefined gene sets; a negative result does not exclude a genetic cause outside the tested regions.
For broader diagnostic insight, Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), or multiomic solutions are recommended.
Price
€1220
General Information
This panel/test is designed for the diagnosis of epilepsy and related neurological disorders. It typically includes a selected set of genes known to be associated with epilepsy, analyzed using Next-Generation Sequencing (NGS) panels or specialized molecular methods such as MLPA, Sanger sequencing, or qPCR for specific variant types.
Technical Specifications
Primary Method: NGS panel (amplicon-based or hybrid capture) covering dozens to hundreds of genes
Possible Add-ons: CNV analysis, repeat expansion testing, mtDNA sequencing if applicable
Validation: Sanger sequencing or MLPA for key variants when needed
Sample & Conditions
EDTA blood is the most commonly used sample; saliva or tissue may also be accepted.
Turnaround Time
Typically 2–6 weeks, depending on the panel and any required reflex testing.
Limitations / Recommendations
Panels are limited to predefined gene sets; a negative result does not exclude a genetic cause outside the target regions.
For broader diagnostic insight, Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), or multiomic approaches are recommended.
Price
€1015
General Information
This panel/test is designed for the diagnosis of intellectual disability and related neurodevelopmental disorders. It typically includes a selected set of genes known to be associated with these conditions, analyzed using Next-Generation Sequencing (NGS) panels or specialized molecular methods such as MLPA, Sanger sequencing, or qPCR for specific variants.
Technical Specifications
Primary Method: NGS panel (amplicon-based or hybrid capture) covering dozens to hundreds of genes
Possible Add-ons: CNV analysis, repeat expansion testing, mtDNA sequencing if needed
Validation: Sanger sequencing or MLPA used for key variants when appropriate
Sample & Conditions
EDTA blood is the most commonly used sample; saliva or tissue samples may also be accepted.
Turnaround Time
Typically 2–6 weeks, depending on the panel and any required reflex testing.
Limitations / Recommendations
Panels cover predefined gene sets; a negative result does not exclude a genetic cause outside these regions.
For broader diagnostic insight, Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), or multiomic approaches are recommended.
Price
€1220
General Information
This panel/test is designed for the diagnosis of myeloid tumors and related hematologic disorders. It typically includes a selected set of genes known to be associated with these conditions, analyzed using Next-Generation Sequencing (NGS) panels or specialized molecular techniques such as MLPA, Sanger sequencing, or qPCR for specific variants.
Technical Specifications
Primary Method: NGS panel (amplicon-based or hybrid capture) covering dozens to hundreds of genes
Possible Add-ons: CNV analysis, repeat expansion detection, mtDNA sequencing as needed
Validation: Sanger sequencing or MLPA for key variants when required
Sample & Conditions
EDTA blood is the most commonly used sample; saliva or tissue may also be accepted depending on the case.
Turnaround Time
Typically 2–6 weeks, depending on the panel and any reflex testing required.
Limitations / Recommendations
Panels target predefined gene sets; a negative result does not exclude a genetic cause outside the tested regions.
For broader diagnostic coverage, Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), or multiomic analyses are recommended.
Price
€1015
General Information
This panel/test is designed for the diagnosis of neuromuscular disorders. It typically includes a selected set of genes known to be associated with the relevant diseases or syndromes, analyzed using Next-Generation Sequencing (NGS) panels or specific molecular methods such as MLPA, Sanger sequencing, or qPCR for certain variants.
Technical Specifications
Primary Method: NGS panel (amplicon-based or hybrid capture) covering dozens to hundreds of genes
Possible Add-ons: CNV analysis, repeat expansion detection, mtDNA sequencing as needed
Validation: Sanger sequencing or MLPA for key variants when required
Sample & Conditions
EDTA blood is the most commonly used sample; saliva or tissue may be accepted depending on the case.
Turnaround Time
Typically 2–6 weeks, depending on the panel and any reflex testing required.
Limitations / Recommendations
Panels target predefined gene sets; a negative result does not exclude a genetic cause outside the tested regions.
For broader exploration, Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), or multiomic approaches are recommended.
Price
€1015
General Information
This panel/test is aimed at diagnosing the clinical condition indicated in the title. It typically includes a selected set of genes known to be associated with pancreatitis, analyzed using Next-Generation Sequencing (NGS) gene panels or specific molecular methods such as MLPA, Sanger sequencing, or qPCR for certain variants.
Technical Specifications
Primary method: NGS panel (amplicon-based or hybrid capture) covering dozens to hundreds of genes
Possible additions: CNV analysis, repeat expansion testing, mtDNA sequencing if needed
Validation: Confirmatory testing using Sanger sequencing or MLPA for key variants when necessary
Sample & Conditions
EDTA blood is the most commonly used sample; saliva or tissue may also be accepted, depending on the case.
Turnaround Time
Typically 2–6 weeks, depending on the panel and any reflex testing required.
Limitations / Recommendations
Panels target predefined genes; a negative result does not exclude a genetic cause outside the covered gene set.
For broader analysis, Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), or multiomic approaches may be recommended.
Price
€815
General Information
This panel/test is intended for diagnosing the clinical condition stated in the title. It typically includes a selected set of genes known to be associated with Parkinson’s disease, analyzed using Next-Generation Sequencing (NGS) gene panels or specific molecular methods such as MLPA, Sanger sequencing, or qPCR for certain variants.
Technical Specifications
Primary method: NGS panel (amplicon-based or hybrid capture) covering tens to hundreds of genes
Possible additions: CNV analysis, repeat expansion testing, mtDNA sequencing if needed
Validation: Confirmatory analysis via Sanger sequencing or MLPA for important variants when required
Sample & Conditions
EDTA blood is the most commonly used sample; saliva or tissue may also be accepted, depending on the case.
Turnaround Time
Typically 2–6 weeks, depending on the panel and any reflex testing required.
Limitations / Recommendations
The panel targets predefined genes; a negative result does not exclude a genetic cause outside the covered gene set.
For broader analysis, Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), or multiomic approaches may be recommended.
Price
€815
General Information
This panel/test is designed for diagnosing disorders related to the pulmonary system. It usually includes a selected set of genes known to be associated with specific lung diseases or syndromes, analyzed using Next-Generation Sequencing (NGS) panels or specific molecular methods such as MLPA, Sanger sequencing, or qPCR for certain variants.
Technical Specifications
Primary method: NGS panel (amplicon-based or hybrid capture) covering tens to hundreds of genes
Possible additions: CNV analysis, repeat expansion testing, mtDNA sequencing if needed
Validation: Confirmatory testing via Sanger sequencing or MLPA for key variants when required
Sample & Conditions
EDTA blood is the most commonly used sample; saliva or tissue may also be used in some cases.
Turnaround Time
Typically 2–6 weeks, depending on the panel and any necessary reflex tests.
Limitations / Recommendations
The panel is limited to predefined genes; a negative result does not exclude a genetic cause outside the genes analyzed.
For more extensive diagnostic evaluation, Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), or multiomic solutions may be recommended.
Price
€1015
General Information
This panel/test is designed for the diagnosis of disorders associated with solid tumors. It typically includes a selected panel of genes known to be linked to specific cancers or syndromes, analyzed using Next-Generation Sequencing (NGS) panels or other molecular techniques such as MLPA, Sanger sequencing, or qPCR for specific variants.
Technical Specifications
Primary method: NGS panel (amplicon-based or hybrid capture) covering tens to hundreds of genes
Possible add-ons: CNV analysis, repeat expansion testing, mtDNA analysis when indicated
Validation: Confirmation of key variants via Sanger sequencing or MLPA, if required
Sample & Conditions
EDTA blood is the most commonly used sample; saliva or tissue samples may also be used in certain cases.
Turnaround Time
Typically 2–6 weeks, depending on the panel configuration and whether additional reflex testing is needed.
Limitations / Recommendations
Panels include only predefined genes, so a negative result does not rule out a genetic cause outside the tested genes.
For broader investigation, Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), or multiomic approaches are recommended.
Price
€915
Book an appointment
Our specialists will care for you with a personalized approach, ensuring the best possible outcomes.